CRVS
#2497
Corvus Pharmaceuticals, Inc. - Common Stock
10.0 5 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.47%
Variación mensual
-22.21%
Variación en los últimos 6 meses
-33.93%
Cambio anual
+45.65%
Cierres anteriores
10.5 2
Open
10.4 3
Mínimo
10.0 2
Máximo
10.5 0
Financials
- Market Capitalization 845.42 M
- Employee 37
- Founded 2014
- CEO N/A
- Website www.corvuspharma.com
- Headquarter Delaware, United States
- FIGI BBG009F0TGH8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14.53
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2456 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.52 USD | +2.14% | +1.35% | -26.69% | -6.90% | 897.50 M USD | ||
| 2463 |  JBIO Jade Biosciences, Inc. - Common Stock | 14.00 USD | -2.71% | +2.49% | -22.48% | +39.30% | 890.36 M USD | ||
| 2514 |  ABUS Arbutus Biopharma Corporation - Common Stock | 4.15 USD | -1.66% | -11.13% | -18.95% | -2.35% | 821.07 M USD | ||
| 2526 |  AVBP ArriVent BioPharma, Inc. - Common Stock | 16.46 USD | -1.61% | +37.97% | -43.44% | -20.41% | 811.61 M USD |